Logo image of DOX.MI

DOXEE SPA (DOX.MI) Stock Fundamental Analysis

BIT:DOX - Euronext Milan - IT0005394413 - Common Stock - Currency: EUR

1.425  +0.03 (+1.79%)

Fundamental Rating

2

DOX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 94 industry peers in the Software industry. DOX may be in some trouble as it scores bad on both profitability and health. DOX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DOX has reported negative net income.
In the past year DOX had a positive cash flow from operations.
Of the past 5 years DOX 4 years were profitable.
In the past 5 years DOX always reported a positive cash flow from operatings.
DOX.MI Yearly Net Income VS EBIT VS OCF VS FCFDOX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

DOX's Return On Assets of -9.66% is on the low side compared to the rest of the industry. DOX is outperformed by 69.15% of its industry peers.
DOX has a worse Return On Equity (-42.86%) than 73.40% of its industry peers.
Industry RankSector Rank
ROA -9.66%
ROE -42.86%
ROIC N/A
ROA(3y)-1.48%
ROA(5y)1.53%
ROE(3y)-19.24%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
DOX.MI Yearly ROA, ROE, ROICDOX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 2K 4K 6K

1.3 Margins

DOX's Gross Margin of 61.63% is in line compared to the rest of the industry. DOX outperforms 45.74% of its industry peers.
In the last couple of years the Gross Margin of DOX has declined.
The Profit Margin and Operating Margin are not available for DOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-7.14%
DOX.MI Yearly Profit, Operating, Gross MarginsDOX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

DOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DOX has less shares outstanding than it did 1 year ago.
DOX has more shares outstanding than it did 5 years ago.
DOX has a worse debt/assets ratio than last year.
DOX.MI Yearly Shares OutstandingDOX.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
DOX.MI Yearly Total Debt VS Total AssetsDOX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.24, we must say that DOX is in the distress zone and has some risk of bankruptcy.
DOX has a Altman-Z score of 0.24. This is in the lower half of the industry: DOX underperforms 76.60% of its industry peers.
A Debt/Equity ratio of 1.31 is on the high side and indicates that DOX has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.31, DOX is doing worse than 78.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Altman-Z 0.24
ROIC/WACCN/A
WACC9.04%
DOX.MI Yearly LT Debt VS Equity VS FCFDOX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

DOX has a Current Ratio of 0.66. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DOX (0.66) is worse than 81.91% of its industry peers.
DOX has a Quick Ratio of 0.66. This is a bad value and indicates that DOX is not financially healthy enough and could expect problems in meeting its short term obligations.
DOX's Quick ratio of 0.66 is on the low side compared to the rest of the industry. DOX is outperformed by 81.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
DOX.MI Yearly Current Assets VS Current LiabilitesDOX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

DOX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.07%.
Looking at the last year, DOX shows a small growth in Revenue. The Revenue has grown by 5.33% in the last year.
Measured over the past years, DOX shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44%
Revenue 1Y (TTM)5.33%
Revenue growth 3Y13.43%
Revenue growth 5Y13.47%
Sales Q2Q%3.22%

3.2 Future

Based on estimates for the next years, DOX will show a very strong growth in Earnings Per Share. The EPS will grow by 34.84% on average per year.
The Revenue is expected to grow by 13.10% on average over the next years. This is quite good.
EPS Next Y30.2%
EPS Next 2Y42.87%
EPS Next 3Y34.84%
EPS Next 5YN/A
Revenue Next Year18.71%
Revenue Next 2Y14.6%
Revenue Next 3Y13.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DOX.MI Yearly Revenue VS EstimatesDOX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DOX.MI Yearly EPS VS EstimatesDOX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DOX. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 70.54 indicates a quite expensive valuation of DOX.
DOX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.38. DOX is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 70.54
DOX.MI Price Earnings VS Forward Price EarningsDOX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DOX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.82
DOX.MI Per share dataDOX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DOX does not grow enough to justify the current Price/Earnings ratio.
DOX's earnings are expected to grow with 34.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.87%
EPS Next 3Y34.84%

More info and screens

0

5. Dividend

5.1 Amount

DOX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOXEE SPA

BIT:DOX (4/23/2025, 7:00:00 PM)

1.425

+0.03 (+1.79%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.37M
Analysts80
Price Target6.86 (381.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-322.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.54
P/S 0.62
P/FCF N/A
P/OCF 3.81
P/B 1.64
P/tB N/A
EV/EBITDA 39.82
EPS(TTM)-0.42
EYN/A
EPS(NY)0.02
Fwd EY1.42%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.37
OCFY26.27%
SpS2.28
BVpS0.87
TBVpS-1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.66%
ROE -42.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.63%
FCFM N/A
ROA(3y)-1.48%
ROA(5y)1.53%
ROE(3y)-19.24%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-7.14%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Debt/EBITDA 15.95
Cap/Depr 163.57%
Cap/Sales 29.99%
Interest Coverage N/A
Cash Conversion 527.09%
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z 0.24
F-Score5
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)25.66%
Cap/Sales(5y)24.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44%
EPS Next Y30.2%
EPS Next 2Y42.87%
EPS Next 3Y34.84%
EPS Next 5YN/A
Revenue 1Y (TTM)5.33%
Revenue growth 3Y13.43%
Revenue growth 5Y13.47%
Sales Q2Q%3.22%
Revenue Next Year18.71%
Revenue Next 2Y14.6%
Revenue Next 3Y13.1%
Revenue Next 5YN/A
EBIT growth 1Y-131.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2577.72%
EBIT Next 3Y257.58%
EBIT Next 5YN/A
FCF growth 1Y-201.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.01%
OCF growth 3Y-24.68%
OCF growth 5Y-0.09%